← Leaderboards
Robert Keith
Va Eastern Colorado Health Care System
$1,357,712
Attributed
$1,357,712
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $285.8K · FY2011–20$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,357,712 · 1
VA$0 · 2
By mechanism
P50$1,357,712 · 1
I01$0 · 1
IS1$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasm Of Lung”
- David Heimbrook · Leidos Biomedical Research, Inc.$349,639,893
- Richard K. Wilson · Washington University$202,666,376
- Walter John Curran · Thomas Jefferson University$94,674,902
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$61,410,512
- Norman Wolmark · Nsabp Foundation, Inc.$54,610,124
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
Research focus
Malignant Neoplasm Of LungPathway InteractionsChemopreventionFutureGrantFundingLaboratoriesBiopsyLungScreeningClinical TrialsMalignant NeoplasmsHigh RiskGenesPpar GammaCellsPrevention StrategyVeteransAgonistCancer ChemopreventionDiabetes MellitusDiagnosisAnimalsAnalog
Grant awards (16)
PPAR gamma Agonists for Lung Cancer Chemoprevention$0
I01 · FY2020 · VA · contact PI
PPAR gamma Agonists for Lung Cancer Chemoprevention$0
I01 · FY2019 · VA · contact PI
Clinical Trials Core$279,710
P50 · FY2018 · CA · contact PI
Clinical Trials Core$6,134
P50 · FY2018 · CA · contact PI
PPAR gamma Agonists for Lung Cancer Chemoprevention$0
I01 · FY2018 · VA · contact PI
Clinical Trials Core$283,712
P50 · FY2017 · CA · contact PI
PPAR gamma Agonists for Lung Cancer Chemoprevention$0
I01 · FY2017 · VA · contact PI
Clinical Trials Core$263,026
P50 · FY2016 · CA · contact PI
ShEEP Request for Nanostring nCounter Spring Profiler$0
IS1 · FY2016 · VA · contact PI
PPAR gamma Agonists for Lung Cancer Chemoprevention$0
I01 · FY2016 · VA · contact PI
Clinical Trials Core$263,308
P50 · FY2015 · CA · contact PI
Clinical Trials Core$261,822
P50 · FY2014 · CA · contact PI
PPAR gamma Agonists for Lung Cancer Chemoprevention$0
I01 · FY2014 · VA · contact PI
PPAR gamma Agonists for Lung Cancer Chemoprevention$0
I01 · FY2013 · VA · contact PI
PPAR gamma Agonists for Lung Cancer Chemoprevention$0
I01 · FY2012 · VA · contact PI
PPAR gamma Agonists for Lung Cancer Chemoprevention$0
I01 · FY2011 · VA · contact PI